Hormonal predictors of prostate cancer

Urologia Internationalis

Volumn 79, Issue 1, 2007, Pages 13-18

  Sofikerim, Mustafa ^a   Eskicorapci, Sadettin ^a   Ozruç, Özgür ^a   Özen, Haluk ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Follicle stimulating hormone; Luteinizing hormone; Prostate biopsy; Prostate cancer; Prostate specific antigen; Testosterone

Indexed keywords

ANDROGEN; FOLLITROPIN; LUTEINIZING HORMONE; PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE;

ADULT; AGE DISTRIBUTION; AGED; ANDROGEN BLOOD LEVEL; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RISK; CONTROLLED STUDY; DIGITAL RECTAL EXAMINATION; FOLLITROPIN BLOOD LEVEL; HUMAN; LOGISTIC REGRESSION ANALYSIS; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; STATISTICAL ANALYSIS; TESTOSTERONE BLOOD LEVEL; TUMOR BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; FOLLICLE STIMULATING HORMONE; HUMANS; LUTEINIZING HORMONE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY; TESTOSTERONE;

EID: 34447299663     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000102906     Document Type: Article

References (18)

1. Ross R, Bernstein L, Judd H, Hanisch R, Pike M, Henderson B: Serum testosterone levels in healthy young black and white men. J Natl Cancer Inst 1986;76:45.
2. Mohr AB, Feldman AH, Kalish L, Longcope C, McKinlay JB: Are serum hormones associated with the risk of prostate cancer? Prospective results from the Massachusetts Male Aging Study. Urology 2001;57:930-935.
3. Eskicorapci SY, Baydar DE, Akbal C, Sofikerim M, Gunay M, Ekici S, Ozen H: An extended 10-core transrectal ultrasonography guided prostate biopsy protocol improves the detection of prostate cancer. Eur Urol 2004;45:444-448.
4. Eskicorapci SY, Guliyev F, Akdogan B, Dogan HS, Ergen A, Ozen H: Individualization of the biopsy protocol according to the prostate gland volume for prostate cancer detection. J Urol 2005;173:1536-1540.
5. Gleason DF, Veterans Administration Cooperative Urological Research Group: Histologic grading and clinical staging of prostatic carcinoma; in Tannenbaum M (ed): Urologic Pathology: The Prostate. Philadelphia, Lea & Febiger, 1977.
6. Morgentaler A, Bruning CO, DeWolf WC: Occult prostate cancer in men with low testosterone levels. JAMA 1996;276:1904-1906.
7. Hoffman M, DeGolf W, Morgenthaler A: Is low serum free testosterone a marker for high grade prostate cancer? J Urol 2000;163:824-827.
8. Andersson SO, Adami HO, Bergström R, Wide l: Serum pituitary and sex steroid hormone levels in the etiology of prostatic cancer - a population-based case-control study. Br J Cancer 1993;68:97-102.
9. Nomura A, Heilbrun LK, Stemmermann GN, Judd HL: Prediagnostic hormones and the risk of prostate cancer. Cancer Res 1988;48:3515-3517.
10. Barrett-Connor E, Garland C, McPhillips JB, Khaw KT, Wingard DL: A prospective, population-based study of androstenedione, estrogens, and prostatic cancer. Cancer Res 1990;50:169-173.
11. Nomura AM, Stemmermann GN, Chyou PH, Henderson BE, Stanczyk FZ: Serum androgens and prostate cancer. Cancer Epidemiol Biomarkers Prev 1996;5:621-625.
12. Chen C, Weiss SN, Stancyzk FZ, Lewis SK, DiTommaso D, Etzioni R, Barnett MJ, Goodman GE: Endogeneous sex hormones and prostate cancer risk: a case-control study nested within the caratone and retinol efficacy trial. Cancer Epidemiol Biomarkers Prev 2003;12:1410-1416.
13. Bolelli G, Muti P, Micheli A, Sciajno R, Franceschetti Berrino F: Validity for epidemiological studies of long-term crycon and protein hormones in serum and plasma. Cancer Epidemiol Biomarkers Prev 1995;4:509-513.
14. Meikle AW, Smith JA, Stringham JD: Production, clearance, and metabolism of testosterone in men with prostatic cancer. Prostate 1987;10:25-31.
15. Stattin P, Lumme S, Tenkanen L, Alfthan H, Jellum E, Hallmans G, Thoresen S, Hakulinen T, Luostarinen T, Lehtinen M, Dillner J, Stenman UH, Hakama M: High levels of circulating testosterone are not associated with increased prostate cancer risk: a pooled prospective study. Int J Cancer 2004;108:418-424.
16. Bosland MC: The role of steroid hormones in prostate carcinogenesis. J Natl Cancer Inst 2000;27:67-73.
17. Miller LR, Partin AW, Chan DW, Bruzek DJ, Dobs AS, Epstein JI, Walsh PC: Influence of radical prostatectomy on serum hormone levels. J Urol 1998;160:449-453.
18. Hilz H, Graefen M, Noldus J, Hammerer P, Knabbe C, Huland E, Huland H: Advanced prostate cancer is associated with a decrease in serum luteinizing hormone. Eur Urol 2000;38:243-249.